m 16209 has been researched along with tolbutamide in 1 studies
| Studies (m 16209) | Trials (m 16209) | Recent Studies (post-2010) (m 16209) | Studies (tolbutamide) | Trials (tolbutamide) | Recent Studies (post-2010) (tolbutamide) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 5,368 | 238 | 265 |
| Protein | Taxonomy | m 16209 (IC50) | tolbutamide (IC50) |
|---|---|---|---|
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.392 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, K; Kato, K; Miwa, I; Mizota, M; Murakami, N; Ohta, M; Okuda, J | 1 |
1 other study(ies) available for m 16209 and tolbutamide
| Article | Year |
|---|---|
Acceleration of glycolysis in erythrocytes by the antidiabetic agent M16209.
Topics: Aldehyde Reductase; Animals; Benzofurans; Erythrocytes; Glucose; Glyceraldehyde; Glycolysis; Humans; Hydantoins; Hypoglycemic Agents; Imidazoles; Imidazolidines; In Vitro Techniques; Lactic Acid; Male; Phosphofructokinase-1; Rats; Rats, Wistar; Tolbutamide | 1996 |